Literature DB >> 8997560

High predictive value of Toxoplasma gondii IgG antibody levels in HIV-infected patients for diagnosis of cerebral toxoplasmosis.

C Hellerbrand1, F D Goebel, R Disko.   

Abstract

The results of serological tests for Toxoplasma gondii IgG in 31 HIV-infected patients with toxoplasmic encephalitis (TE) and 49 HIV-infected patients seropositive for Toxoplasma gondii but without TE were compared. All patient had a CD4+ lymphocyte count < 150/microliters. Of the TE patients, 22 (71%) were designated as having relatively high IgG levels on the basis of the following Toxoplasma IgG titre combination: Sabin-Feldman test > or = 1:256, indirect hemagglutination test > or =1:1024, direct agglutination test > or = 1:14,580. Only 3 patients without TE had relatively high IgG titres. Relatively high IgG titres indicated TE with a positive predictive value of 88% in HIV-infected patients with CD4+ cell counts < 150/microliters, and could be observed in most patients several months prior to the first clinical and radiological signs of TE.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997560     DOI: 10.1007/bf01691219

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

Review 1.  [Fever in HIV-1 infection].

Authors:  G Fätkenheuer; M Schrappe-Bächer; B Salzberger; H M Steffen; S Degenhardt; B Allolio; W Kaufmann
Journal:  Dtsch Med Wochenschr       Date:  1989-07-28       Impact factor: 0.628

2.  Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy.

Authors:  C Wanke; C U Tuazon; A Kovacs; T Dina; D O Davis; N Barton; D Katz; M Lunde; C Levy; F K Conley
Journal:  Am J Trop Med Hyg       Date:  1987-05       Impact factor: 2.345

Review 3.  AIDS commentary. Toxoplasmic encephalitis.

Authors:  B J Luft; J S Remington
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

Review 4.  Toxoplasmosis: an update on clinical and therapeutic aspects.

Authors:  C F Decker; C U Tuazon
Journal:  Prog Clin Parasitol       Date:  1993

5.  Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome.

Authors:  S B Porter; M A Sande
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

6.  Biology of Toxoplasma gondii.

Authors:  S Y Wong; J S Remington
Journal:  AIDS       Date:  1993-03       Impact factor: 4.177

7.  Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome.

Authors:  B J Luft; R G Brooks; F K Conley; R E McCabe; J S Remington
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

8.  Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG.

Authors:  E N Janoff; W D Hardy; P D Smith; S M Wahl
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

9.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

10.  Disseminated toxoplasmosis in AIDS patients--report of 16 cases.

Authors:  H Albrecht; J Skörde; K Arasteh; W Heise; H J Stellbrink; G Grosse; M L'Age
Journal:  Scand J Infect Dis       Date:  1995
View more
  9 in total

1.  Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples.

Authors:  Fabio A Colombo; José E Vidal; Augusto C Penalva de Oliveira; Adrián V Hernandez; Francisco Bonasser-Filho; Roberta S Nogueira; Roberto Focaccia; Vera Lucia Pereira-Chioccola
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS.

Authors:  R F Miller; M A Hall-Craggs; D C Costa; N S Brink; F Scaravilli; S B Lucas; I D Wilkinson; P J Ell; B E Kendall; M J Harrison
Journal:  Sex Transm Infect       Date:  1998-08       Impact factor: 3.519

3.  The probability of acquiring primary Toxoplasma infection in HIV-infected patients: results of an 8-year retrospective study.

Authors:  I Reiter-Owona; R Bialek; J K Rockstroh; H M Seitz
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

4.  Improved diagnosis of reactivated toxoplasmosis.

Authors:  D Ashburn; M M Davidson; A W Joss; T H Pennington; D O Ho-Yen
Journal:  Mol Pathol       Date:  1998-04

Review 5.  Streptococcus anginosus (Streptococcus milleri Group) Pyomyositis in a 50-Year-Old Man with Acquired Immunodeficiency Syndrome: Case Report and Review of Literature.

Authors:  M Yassin; G K Yadavalli; N Alvarado; R A Bonomo
Journal:  Infection       Date:  2009-11-10       Impact factor: 3.553

6.  Evaluation of a PCR assay for diagnosis of toxoplasmosis in serum and peripheral blood mononuclear cell among HIV/AIDS patients.

Authors:  Farah Bokharaei-Salim; Abdoulreza Esteghamati; Khadijeh Khanaliha; Saeed Kalantari; Shirin Sayyahfar; Tahereh Donyavi; Saba Garshasbi; Qasem Asgari; Borna Salemi
Journal:  J Parasit Dis       Date:  2019-12-11

7.  Patterns of Toxoplasma gondii cyst distribution in the forebrain associate with individual variation in predator odor avoidance and anxiety-related behavior in male Long-Evans rats.

Authors:  Andrew K Evans; Patrick S Strassmann; I-Ping Lee; Robert M Sapolsky
Journal:  Brain Behav Immun       Date:  2013-11-21       Impact factor: 7.217

8.  Seroprevalence of Toxoplasma gondii in newly diagnosed HIV seropositive patients.

Authors:  Anuja Dutta; Preeti R Mehta; Nayana Ingole
Journal:  Indian J Med Res       Date:  2020-11       Impact factor: 2.375

9.  Serological Responses to Toxoplasma gondii and Matrix Antigen 1 Predict the Risk of Subsequent Toxoplasmic Encephalitis in People Living With Human Immunodeficiency Virus (HIV).

Authors:  Jianchun Xiao; Fiona Bhondoekhan; Eric C Seaberg; Otto Yang; Valentina Stosor; Joseph B Margolick; Robert H Yolken; Raphael P Viscidi
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.